Understanding the Pathogenesis of Gestational Hypothyroidism

Area of Science:

• Endocrinology
• Reproductive Medicine
• Maternal-Fetal Medicine

Background:

• Gestational Hypothyroidism (GHT) is thyroid insufficiency developing during pregnancy in previously euthyroid women.
• Overt hypothyroidism during pregnancy has known adverse maternal and fetal effects.
• GHT is linked to adverse outcomes including miscarriage, pre-eclampsia, and impaired fetal neurodevelopment.

Purpose of the Study:

• To review pregnancy-induced physiological challenges that may lead to Gestational Hypothyroidism.
• To explore the mechanisms underlying the development of GHT.
• To contextualize the ongoing debate on the benefits and risks of levothyroxine treatment for GHT.

Main Methods:

• Literature review of physiological changes during pregnancy affecting thyroid function.
• Analysis of hormonal and placental factors influencing maternal thyroid status.
• Examination of evidence regarding levothyroxine treatment for GHT.

Main Results:

• Pregnancy involves increased iodine clearance, elevated estrogen impacting thyroglobulin and free thyroxine levels.
• Placental hormones like hCG, PIGF, and s-Flt1 may influence thyroid function.
• Recent studies indicate no neurodevelopmental benefit from levothyroxine treatment for GHT, raising concerns about over-treatment risks.

Conclusions:

• Physiological adaptations during pregnancy, including hormonal shifts and placental factors, are hypothesized to contribute to GHT.
• The clinical benefit of levothyroxine treatment for GHT remains debated due to conflicting evidence and potential risks.
• Further elucidation of regulatory mechanisms is needed to understand GHT development and guide clinical management.